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DHowever, we are the first to look specifically at the results
of combined valve-sparing aortic root and complex aortic
valve repairs in a pediatric population. The finding of worse
outcomes in valve-sparing aortic root replacement and
reimplantation is, admittedly, surprising and suggests a
technical issue, with the interesting finding that the graft
to root diameter ratio was smaller in the reimplantation
group, and that smaller graft to annulus diameter ratio is a
predictor of SVD. Furthermore, 4 patients with SVD had
an intact repair, with prolapse of 1 or 3 leaflets. This
suggests that the graft during reimplantation may have
been undersized, setting up for a higher risk of SVD because
this creates a valve with a surface area of cusp tissue too
large for the new, downsized annulus with a lower level of
cusp coaptation, leading to cusp prolapse and regurgitation.
This limited coaptation reserve predisposes to regurgitation.
El Khoury and colleagues13 have proposed a simple,
reproducible technique for graft-sizing for reimplantation,
using the height of the interleaflet triangle between the
left and noncoronary leaflets, which corresponds to the
external diameter of the STJ of a competent aortic valve
(and to choose the next larger graft size if the distance
does not correspond with a labeled graft size to avoid
undersizing).CONCLUSIONS
Combined valve-sparing root and aortic valve recon-
struction can be done with low operative risk and allows
valve preservation in a majority of patients at midterm
follow-up. Although root replacement with reimplantation
was previously shown to have better outcomes than remod-
eling in children, these data should caution the same
assumption being made when associated with complex
aortic valve reconstruction. Adequate graft sizing is
important for the durability of repair, and undersizing
should be avoided to prevent SVD. Although we did not
find that the presence of connective tissue disorder was a
risk factor for SVD, we have adopted an institutional policy
of repairing the valve at the time of root replacement or
remodeling only when minor defects are present.References
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Dr Duke E. Cameron (Baltimore, Md). You have described a
very valuable experience with a challenging group of patients,
namely children with aortic root aneurysms and significant valve
disease that is not simply the result of a dilated root. Two-thirds
of these patients had already had previous congenital heart repairs.
That is what distinguishes your series from most other series,
including ours at Hopkins, where the majority of our patients
have connective tissue disorders, no previous surgery, and much
less aortic regurgitation, often none.
You have demonstrated that these operations are safe and that
good outcomes are achievable, at least in early follow-up, in nearlygery c June 2014
Myers et al Congenital Heart Disease
C
H
Dthree-quarters of your patients. Your intriguing finding is that the
patients who had reimplantation procedures had worse outcomes
in terms of recurrent aortic regurgitation than those who had
remodeling operations. This is in sharp contrast, as you pointed
out, with most other reports where reoperation rate and recurrent
aortic regurgitation are better with reimplantation presumably
because of annular stabilization.
You have also suggested that this may have been a graft sizing
problem. Perhaps your grafts were too small for that root and they
may have crumpled the valve, induced prolapse, and perhaps
forced you to do an aortic valve repair. I suspect you are right,
and this is supported by the fact that your reimplantation patients
had a much more severe reduction in the root diameter than the
remodeling group.
But I disagree with the implication that the problem is the
reimplantation technique itself. Indeed, because most of the
surgeons here today will be performing these operations in patients
with connective tissue disorders, such as Marfan syndrome and
Loeys-Dietz syndrome, it is important to stress that annular
stabilization, which is achieved reliably only by the reimplantation
technique and appropriate graft sizing, are the key to good
long-term results. This has been amply demonstrated in both
children and adults.
I would also like to challenge the notion that aortic regurgitation
often precludes valve-sparing procedures. This depends entirely
on the mechanism of regurgitation. If the cusps are normal or
they are only mildly stretched and the regurgitation is due to
dilation of the annulus or sinotubular junction (STJ), then durable
valve competence is often achieved just by reducing the annulus
and STJ, as appropriate. With leaflet disease it is a different matter,
but it may still be repairable. We should approach each of these
cases individually and intraoperative assessment is absolutely
crucial.
So my questions are, first, by what method did you choose graft
size, and have you changed that approach since reviewing these
findings? Second, when you reoperated on patients for AR, what
were the findings? Why were the valves leaking?
Finally, I noted in your work that STJ stabilization was achieved
in all of your reimplantation patients, which is what we would
expect, but only 60% of the remodeling patients. I do not quite
understand that, because both of these operations should stabilize
the STJ.
Dr Myers. Thank you very much for the very interesting
questions. It is an honor to have questions from such an expert
on valve-sparing aortic root procedures.
These procedures were done by 6 to 7 different surgeons who
each had his or her own method. The main method used was to
evaluate the annular size and approximate into what size graft
the leaflets could be resuspended without undergoing a significant
aortic valvuloplasty, if that was possible. There was not any sys-
tematic formula or measurement, as has been described in adults.
Regarding the mechanism of failure, it was interesting that of
the 7 patients who had failure, 4 had an intact repair when the valve
was reevaluated surgically, and there was prolapse of all 3 leaflets.
This could, again, indicate that the resuspension or the repair had a
deficient coaptation height, which progressed to prolapse with
time. Although we initially had a favorable result that obviously
was not the case over time.The Journal of Thoracic and CarTwo patients had issues with leaflet augmentation. In 1 patient
the augmented leaflet had retracted, was deficient, and the
regurgitant jet was along this leaflet. The second patient had a
CorMatrix leaflet (CorMatrix Inc, Alfpharetta, Ga) that, on the
other hand, was too floppy and prolapsed past the point of
coaptation. The final patient had rupture of resuspension stitches
associated with tears in the leaflets that were deemed not to be
repairable and so the valve was replaced.
As I showed, the remodeling group is actually quite different
from those reported in most of the series and your own, where
root remodeling has predominantly been a Yacoub-type operation.
Here we have other types of procedures, with sinus reduction and
resection or annular and STJ stabilization, and only 5 Yacoub
procedures. Overall in this group, it was actually a fairly limited
procedure from the aortic root standpoint and more predominantly
a procedure on the aortic valve repair. So in these patients most
often the annulus was not stabilized and the ascending aorta was
not necessarily replaced.
Dr Cameron. There was no Dacron graft?
Dr Myers. No, that is correct.
Dr Christian Pizarro (Wilmington, Del). That is a very
intriguing problem that we have been trying to deal with during
the past decade. There are data published by Dr David as well as
Gebrine El Khoury from Brussels that illustrate a relatively
constant, reliable methodology as to how to choose the graft,
and that is basically drawing a line between the nadir of the sinuses
and measure the distance (height) between this line and the
intertrigonal space. This correlates quite closely with the
appropriate diameter of a graft, allowing a good match to prevent
the issue that when you downsize too much then the valve will sag
and then you end up with regurgitation.
I am particularly interested in the group of patients with
congenital heart disease. What type of congenital heart disease
did you see most commonly? How many of those patients did
have a bicuspid valve? Were the distributions different between
the 2 techniques? Obviously to do the reimplantation on patients
with bicuspid valve is less challenging in terms of obtaining an
appropriate geometric arrangement.
Dr Myers. On this slide you see the different types of
congenital heart disease, which spanned the whole spectrum of
disease. We looked to see if conotruncal anomalies were a
predictor of structural valve deterioration, with a subannular area
and conus that is much more insecure over time. That was not
the case. Overall there were not any significant differences in the
congenital heart disease.
In terms of valve anatomy, patients who had truncus arteriosus
most often had a quadricuspid valve, had 1 of the leaflets and sinus
resected or reduced, and that was probably a patient whowas more
in the remodeling rather than replacement and reimplantation.
But we also did valve-sparing root replacement with
reimplantation in patients with bicuspid aortic valves associated
with tricuspidization aortic valvuloplasty.
Dr James Quintessenza (St Petersburg, Fla). These are very
challenging patients as we all know, and I would like to push a little
bit more on where we think we might be able to improve,
especially in patients undergoing reimplantation. I assume when
you left the operating room you had 0 to mild regurgitation in those
patients and so therefore over time you saw this deterioration?diovascular Surgery c Volume 147, Number 6 1775
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Dr Quintessenza. We have to assume that we can get a pretty
good repair at the time of the operation and something happens
in terms of biodegenerative process or fibrosis that then results
in insufficiency. That begs the question of the materials we are
using and the techniques we are using. It seems like there is a
heterogeneous kind of approach to the techniques and the
materials.
DrMyers. That is correct. The techniques were at the operating
surgeon’s choice, based on the mechanism, and obviously
dependent on what the individual surgeons were comfortable
doing. With time we have used quite a bit more leaflet patch
augmentations and things like that, and we know that there is an
issue with the patch material deteriorating or retracting over
time, and that obviously goes into the equation of how these valves
do later on.
Dr Quintessenza. Do you have any information, for example,
of materials that you tried that seemed to fail and prompted you
to switch to other materials, and what is your choice for an optimal
material now?
DrMyers.We looked at each 1 of these techniques to see if they
were predictors of structural valve deterioration. Because of our
limited patient numbers, they were not predictors.
For choice of material, we have been using CorMatrix and have
some favorable results with that, and autologous pericardium with
a short treatment time with glutaraldehyde.
Dr Quintessenza. The key is to try to figure out what is the best
material that does not undergo such changes so that we can achieve
a more durable outcome for these patients.
Dr Christopher Caldarone (Toronto, ON, Canada). You had a
reasonable number of patients who had a subannular plication and
a supravalvar tube graft placement of the ascending aorta. Do you
think that is really a valid group to be calling valve-sparing
root replacement and to be comparing with the implantation
technique?
Dr Myers. That is a very good question and obviously a
concern. Professor El Khoury and his group from Belgium have
been pushing this as a form of root remodeling. It is not actually
addressing the sinuses of Valsalva, but it is addressing the annulus1776 The Journal of Thoracic and Cardiovascular Surand the STJ, and then we are addressing the leaflets themselves
with the aortic valve repair.
DrCaldarone. It is a fundamentally different repair. So it is just
a question of whether it is a valid comparison.
The other question I want to ask is in regard to your intra-
operative transesophageal echo results. These valves were all
assessed with intraoperative echocardiograms, and it is quite
possible to have a competent repair that is not a durable repair if
you fail to have an adequate zone of coaptation in the aortic valve
leaflets. It would help to refine your analysis by including those
intraoperative echocardiogram findings. Those may be the biggest
predictor of the durability of these repairs.
Dr Myers. Absolutely. Data in adults have been very clear that
the coaptation height has a significant predictive value. There are
limited results or data for that in children, and unfortunately we did
not measure that systematically, so unfortunately I do not have any
data.
Dr Caldarone. You do have the opportunity to get the data.
Dr Myers. Yes, absolutely.
Dr James Tweddell (Milwaukee, Wis). It seems that the
remodeling procedures you have done are very different than
would be described for the typical child, teenager, or young adult
with a connective tissue disorder and a primary aortopathy. It
seems like a very mixed bag of strategies used to repair the aortic
valve for stenosis or regurgitation, combined with some patients
with connective tissue disorder where it has been used to deal
with dilated sinuses of Valsalva but not primarily aortic valve
pathology. The result is a very difficult comparison within a group
of very challenging group of patients.
Dr Myers. I agree.
Dr V. Mohan Reddy (Stanford, Calif). In this mixed bag of
patients, was there any difference between trileaflet aortic valve
and nontrileaflet aortic valves in terms of interventions?
Dr Myers. No. We looked at valve anatomy as a predictor of
structural valve deterioration, but due to the limited patient
numbers and events, it was not a predictor of structural valve
deterioration.
DrReddy. I would have expected the bicuspid aortic valve to be
less durable than a trileaflet.gery c June 2014
